Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Notes Payables (2020 - 2025)

iBio (IBIO) has disclosed Notes Payables for 6 consecutive years, with $706000.0 as the latest value for Q3 2025.

  • Quarterly Notes Payables rose 211.01% to $706000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $706000.0 through Sep 2025, up 211.01% year-over-year, with the annual reading at $766000.0 for FY2025, 251.38% up from the prior year.
  • Notes Payables for Q3 2025 was $706000.0 at iBio, down from $766000.0 in the prior quarter.
  • The five-year high for Notes Payables was $22.2 million in Q3 2022, with the low at $218000.0 in Q2 2024.
  • Average Notes Payables over 5 years is $8.1 million, with a median of $6.7 million recorded in 2023.
  • The sharpest move saw Notes Payables surged 3593.5% in 2022, then tumbled 98.31% in 2024.
  • Over 5 years, Notes Payables stood at $600000.0 in 2021, then surged by 2568.5% to $16.0 million in 2022, then decreased by 20.96% to $12.7 million in 2023, then tumbled by 95.25% to $601000.0 in 2024, then grew by 17.47% to $706000.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $706000.0, $766000.0, and $824000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.